NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
06/22/2026
Back to search
Official data from USPTO
HYMOVIS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
06/23/2026
Trademark type
Combined
Nice classes
5, 10
Filing date
04/20/2015
Registration date
04/05/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/22/2026
Last transaction
06/23/2026
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
3
Owner type
09
Owner location
Abano Terme (PD), IT
Examiner
SPILS, CAROL A
Current location
Historical data usage
Mark description
The mark consists of the term "HYMOVIS" in which the letter "Y" is comprised of a design representing a human with one leg bended at the hip towards the chest and at the knee.
Holders and representatives
Holders
FIDIA FARMACEUTICI S.p.A.
FIDIA FARMACEUTICI S.p.A.
Representatives
Andrew N. Fredbeck Fross Zelnick Lehrman & Zissu, P.C.
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations in form of hydrogel for medical purposes for the prevention and treatment of articular diseasesdegenerative and traumatic pathologies of joints and of musculoskeletal system and use in orthopaedic surgery; veterinary preparations for the treatment of joint diseases and articular disorders in animals
Class 10
Medical apparatus and instruments for use in orthopaedic surgerysurgery and diagnosis and treatment of rheumatological disorders; medical syringes and cannulae; intra-articular applicators for the administration of pharmaceutical preparations
Publications
History of USPTO decisions and trademark events.
36 publications found
71AG
REGISTERED-SEC.71 ACCEPTED
06/22/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/15/2026
ES71
TEAS SECTION 71 RECEIVED
02/24/2026
RNWL
INTERNATIONAL REGISTRATION RENEWED
05/22/2025
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
04/05/2025
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
07/10/2023
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
06/08/2023
INPC
INVALIDATION PROCESSED
06/07/2023
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
05/06/2023
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
09/06/2022
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
09/06/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/30/2022
ES75
TEAS SECTION 71 & 15 RECEIVED
04/01/2022
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
03/06/2020
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
01/30/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/29/2016
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/11/2016
FIMP
FINAL DISPOSITION PROCESSED
07/11/2016
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/05/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
04/05/2016
PUBO
PUBLISHED FOR OPPOSITION
01/19/2016
NPUB
NOTICE OF PUBLICATION
12/30/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/10/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/20/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/19/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/19/2015
RFNT
REFUSAL PROCESSED BY IB
09/19/2015
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/01/2015
RFRR
REFUSAL PROCESSED BY MPU
09/01/2015
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/29/2015
CNRT
NON-FINAL ACTION WRITTEN
08/28/2015
MAFR
APPLICATION FILING RECEIPT MAILED
08/25/2015
DOCK
ASSIGNED TO EXAMINER
08/21/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/21/2015
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/20/2015
Continuous trademark protection
Get notified about every new filing that threatens HYMOVIS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.